A detailed history of Hobart Private Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hobart Private Capital, LLC holds 840 shares of LLY stock, worth $644,918. This represents 0.19% of its overall portfolio holdings.

Number of Shares
840
Previous 800 5.0%
Holding current value
$644,918
Previous $724 Million 2.75%
% of portfolio
0.19%
Previous 0.21%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$772.14 - $960.02 $30,885 - $38,400
40 Added 5.0%
840 $744 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $257,240 - $299,736
800 New
800 $293 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hobart Private Capital, LLC Portfolio

Follow Hobart Private Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hobart Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hobart Private Capital, LLC with notifications on news.